Healthcare
Nanollose Secured a Development Facility to Increase its Microbial Cellulose Production
January 10, 2019 07:45 PM AEDT| By Team Kalkine MediaToday (i.e., 10 January 2019), leading research and development company, Nanollose Limited (ASX: NC6), announced that it has secured a development facility for scale-up of microbial cellulose production. To increase its commercial-scale fibre product...
FDA Sets Prescription Drug User Fee Act (PDUFA) Date For CLINUVEL’s SCENESSE®
January 10, 2019 04:42 PM AEDT| By Team Kalkine MediaA global biopharmaceutical company, CLINUVEL Pharmaceuticals Limited (ASX: CUV) is in the process of getting approval from US Food and Drug Administration (FDA) for CLINUVEL?s lead compound, SCENESSE? (afamelanotide 16mg), a first-in-class drug targe...
Justice Health Ties Up With Global Health For MasterCare EMR
January 10, 2019 04:34 PM AEDT| By Team Kalkine MediaOn 10 December 2018, Global Health Limited (ASX: GLH) announced the execution of an agreement with Justice Health for the deployment of MasterCare Electronic Medical Record (EMR). The agreement is for a minimum term of 3 years with two further extens...
Launch Of Nuheara’s IQconnect Enhances Customer Hearing Journey
January 10, 2019 04:05 PM AEDT| By Team Kalkine MediaNuheara Limited (ASX: NUH) is a wearable technology company based in Perth, Australia. It has two other offices located in the USA, one in San Francisco and the other in New York. It is one of the leading companies in the world providing smart person...
Improved Quarterly Sales For Summerset, With New Occupation Rights Sales Peaking In Q4 2018
January 10, 2019 03:56 PM AEDT| By Team Kalkine MediaSummerset Group Holdings Limited (ASX: SNZ) has a vision of creating a retirement community with an ideal homely environment for the aged people and a place that will put the respect for its residents at the core of all its activities. It was primari...
Eagle Health Holdings Ltd Introduces A New Brand For Its Line Of Products
January 10, 2019 02:20 PM AEDT| By Team Kalkine MediaEagle Health Holdings Limited (ASX: EHH) has recently announced to have launched its new brand named ?Zhang Lao San.? As previously announced to ASX, the company is committed to executing its plan to open hundred education and experience stores acros...
PATRYS Releases The Corporate Overview Update
January 10, 2019 02:13 PM AEDT| By Team Kalkine MediaOn 9 January 2019, PATRYS LIMITED (ASX: PAB) announced its corporate update. The company is a biopharmaceutical company which develops and commercializes novel antibody technologies to improve clinical outcomes for the cancer patients. Its products P...
MediPharm Labs Enters Into Cannabis Extraction Agreement With TerrAscend Corp
January 10, 2019 01:52 PM AEDT| By Team Kalkine MediaOn 9 January 2019, MMJ Group Holdings Ltd (ASX: MMJ), a global cannabis investment company announced that MediPharm Labs Inc had signed a multi-year cannabis extraction agreement with TerrAscend Corp, a biopharmaceutical and wellness company which is...
Respiri Exhibits At CES In USA To Create Brand Awareness Ahead Of Launching Wheezo ™ In FY19
January 09, 2019 07:26 PM AEDT| By Team Kalkine MediaAustralian Healthcare Company, Respiri Limited (ASX: RSH) made an announcement on 9 January 2019 stating that its exhibit for its Product Wheezo ? has opened at the Consumer Electronics Show, CES 2019, as part of the digital health showcase in Las Ve...
Creso Pharma Eyes Tremendous Growth in New Zealand Cannabis Market
January 09, 2019 06:35 PM AEDT| By Team Kalkine MediaCreso Pharma Limited (ASX: CPH), a cannabis company, today announced the signing of a binding Letter of Intent with Medleaf Ltd to extend its medical cannabis product business in New Zealand. The agreement comes after the significant regulation chan...
Telix Recent Update Emphasizes Its Multibillion Opportunity
January 09, 2019 05:28 PM AEDT| By Team Kalkine MediaTelix Pharmaceuticals Limited (ASX: TLX) operates as a biotechnology company. The Company develops and commercializes molecularly-targeted radiation therapy for the treatment of prostate, renal, and brain cancer. Telix Pharmaceuticals serves patients...
Medlab Reports Significant Improvement In NanoStat™ Compared To Orally Ingested 20 mg Tablet, Atorvastatin
January 09, 2019 04:53 PM AEDT| By Team Kalkine MediaOn 9 January 2019, Medlab Clinical Ltd (ASX: MDC) announced that it has successfully analyzed the results of the NanoStat? bioequivalence trial from Zenith in New Zealand. Although the price of the scrip is trending down from past six months falling...
3 Biotech Stocks Up Today - RVA, IMU And VHT
January 08, 2019 08:01 PM AEDT| By Team Kalkine MediaAfter rallying from a loss in the morning session today as at January 08, 2018, ASX has reached to a month-long high. The Australian biotech market is expected to see growth to ~$25 billion which is currently valued at $23 billion. Australia is ranke...
Telix Pharmaceuticals Ramps Up Its Cancer Therapy Program
January 08, 2019 07:47 PM AEDT| By Team Kalkine MediaBiopharmaceutical player Telix traded at higher levels after the company unveiled the strategy update for its Prostate Cancer Therapy Program. Telix Pharmaceuticals Limited (ASX: TLX) stated that the data analysis and independent monitoring by a thi...
Mesoblast Limited Highlighted Its Commercial And Development Plans At Biotech Showcase 2019
January 08, 2019 07:39 PM AEDT| By Team Kalkine MediaRegenerative medicine company, Mesoblast Limited (ASX: MSB) recently highlighted the commercial and development plans for its lead cellular therapies at the first day of Biotech Showcase 2019 which is being held this week in San Francisco, California...
Oventus Uncovers Next-Generation Oral Device, Stock Up 11%
January 08, 2019 05:26 PM AEDT| By Team Kalkine MediaHealthcare company Oventus Medical Limited wheels the launch of O2Vent? Optima oral device in Australia aimed at the treatment of sleep apnoea. The news sent the OVN stock price to jump up by 11.667% to trade at $0.335 on 8 January 2019 (2:19 PM AEST...
Shares Of Biotech Player Patrys Zoom Up On Receiving R&D Tax Incentive Refund
January 08, 2019 03:19 PM AEDT| By Team Kalkine MediaAs per ASX release dated 8 January 2019, biotechnology player, Patrys Limited (ASX: PAB) announced obtaining $556,129 R&D Tax Incentive Refund for FY 2018 by the Australian Government. R&D Tax Incentive Refund offers refundable tax rebate of...
MMJ Group’s Subsidiary MediPharm Labs Commences Trading in the U.S. on OTCQB Market
January 08, 2019 02:50 PM AEDT| By Team Kalkine MediaGlobal Cannabis Investment Company, MMJ Group Holdings Limited (ASX: MMJ) currently owns around 4.4 million shares for a 4.5 percent shareholding and 2.9 million warrants in Canada?s leading cannabis-focused pharmaceutical company, MediPharm Labs Inc...
The Share Price of RVA Zoomed Up By 21.212% After Its Geographical Expansion Update.
January 07, 2019 11:55 PM AEDT| By Team Kalkine MediaREVA Medical, Inc. (ASX: RVA), a medical device company who is also the leader of bioresorbable polymer technologies announced its geographical expansion in seven European countries along with four new distribution partners. Through this partnership,...
Prana Biotechnology Presents the Treatment of Neurological Disorder – What You Need to Know
January 07, 2019 11:00 PM AEDT| By Team Kalkine MediaPrana Biotechnology Limited (ASX: PBT) is in the healthcare industry develops first-in-class therapies for neurodegenerative diseases to treat orphans. The company has a vast experience in research, pharmaceutical, and financial industries along with...
Advertise your brand on Kalkine Media